Transcode Therapeutics, Inc. SEC filings RNAZ
Transcode Therapeutics, Inc. has 324 filings in SEC EDGAR's recent list, going back to Dec 18, 2020. Its latest annual report, Form ARS, was filed on Jun 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Aug 3, 2026 | Aug 3, 2026 |
| 424B3 | Prospectus | Jul 20, 2026 | — |
| 424B3 | Prospectus | Jul 20, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 20, 2026 | Jul 20, 2026 |
| DEFA14A | Additional proxy material | Jul 17, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 17, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Other events
|
Jul 2, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Other events
|
Jun 3, 2026 | Jun 3, 2026 |
| ARS | Annual report to shareholders | Jun 2, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Jun 2, 2026 | Jul 2, 2026 |
| 8-K | Current report | Jun 1, 2026 | May 29, 2026 |
| DEFA14A | Additional proxy material | May 26, 2026 | — |
| 8-K/A |
Amended current report
Listing notice
|
May 26, 2026 | May 19, 2026 |
| 8-K |
Current report
Listing notice
|
May 22, 2026 | May 19, 2026 |
| EFFECT | Filing | May 19, 2026 | — |
| EFFECT | Filing | May 19, 2026 | — |
| CORRESP | Letter to the SEC | May 15, 2026 | — |
| CORRESP | Letter to the SEC | May 15, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| PRE 14A | Preliminary proxy statement | May 8, 2026 | May 8, 2026 |
| UPLOAD | Letter from the SEC | May 6, 2026 | — |
| UPLOAD | Letter from the SEC | May 6, 2026 | — |
| S-1 | Registration statement | May 1, 2026 | — |
| S-3 | Shelf registration | Apr 30, 2026 | — |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 7, 2026 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Apr 7, 2026 | Apr 6, 2026 |
| NT 10-K | Filing | Mar 31, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 3, 2026 | — |
| 8-K |
Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Mar 3, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 23, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 5, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2026 | Jan 6, 2026 |
| DEFA14A | Additional proxy material | Dec 23, 2025 | — |
| 8-K/A |
Amended current report
Other events
|
Dec 23, 2025 | Oct 8, 2025 |
| EFFECT | Filing | Dec 22, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 22, 2025 | Dec 19, 2025 |
| CORRESP | Letter to the SEC | Dec 18, 2025 | — |
| S-3 | Shelf registration | Dec 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 11, 2025 | Dec 11, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| DEFA14A | Additional proxy material | Oct 27, 2025 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 27, 2025 | Oct 27, 2025 |
| DEFA14A | Additional proxy material | Oct 17, 2025 | — |
| 8-K/A |
Amended current report
Material agreement
|
Oct 17, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Other events
|
Oct 14, 2025 | Oct 13, 2025 |
| DEFA14A | Additional proxy material | Oct 8, 2025 | — |
| 8-K/A |
Amended current report
Material agreement
|
Oct 8, 2025 | Oct 8, 2025 |
| DEFA14A | Additional proxy material | Oct 8, 2025 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 8, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 2, 2025 | Aug 29, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| DEF 14A | Proxy statement | Jul 15, 2025 | Aug 29, 2025 |
| 8-K | Current report | Jun 13, 2025 | Jun 12, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Listing notice
|
May 7, 2025 | May 6, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
May 2, 2025 | May 2, 2025 |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Apr 21, 2025 | Apr 21, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| 10-K | Annual report | Apr 15, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 11, 2025 | Apr 21, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 2, 2025 | Apr 2, 2025 |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 25, 2025 | Mar 23, 2025 |
| 424B5 | Prospectus supplement | Mar 25, 2025 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Feb 25, 2025 | Feb 25, 2025 |
| DEFA14A | Additional proxy material | Feb 4, 2025 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| DEF 14A | Proxy statement | Dec 30, 2024 | Feb 4, 2025 |
| 8-K |
Current report
Other events
|
Dec 20, 2024 | Dec 18, 2024 |
| PRE 14A | Preliminary proxy statement | Dec 19, 2024 | Feb 28, 2025 |
| EFFECT | Filing | Dec 17, 2024 | — |
| CORRESP | Letter to the SEC | Dec 13, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 13, 2024 | — |
| D | Filing | Dec 12, 2024 | — |
| S-1 | Registration statement | Dec 6, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 2, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Nov 29, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 25, 2024 | Nov 22, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Nov 13, 2024 | — |
| DEFA14A | Additional proxy material | Nov 6, 2024 | — |
| 8-K |
Current report
Listing notice
|
Nov 6, 2024 | Nov 4, 2024 |
| DEF 14A | Proxy statement | Oct 28, 2024 | Nov 22, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 27, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Other events
|
Aug 28, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 16, 2024 | Aug 13, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 24, 2024 | Jul 22, 2024 |
| 424B5 | Prospectus supplement | Jul 24, 2024 | — |
| 424B5 | Prospectus supplement | Jul 22, 2024 | — |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| DEFA14A | Additional proxy material | Jun 10, 2024 | — |
| DEFA14A | Additional proxy material | Jun 7, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 7, 2024 | Jun 3, 2024 |
| DEFR14A | Filing | May 20, 2024 | — |
| 8-K |
Current report
Other events
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| DEFA14A | Additional proxy material | May 13, 2024 | — |
| PRE 14A | Preliminary proxy statement | May 10, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Listing notice
|
May 10, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 13, 2024 |
| 8-K | Current report | Apr 23, 2024 | Apr 22, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 5, 2024 | Apr 3, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Jan 31, 2024 | Jan 26, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 22, 2024 | Jan 18, 2024 |
| 424B4 | Prospectus | Jan 22, 2024 | — |
| EFFECT | Filing | Jan 18, 2024 | — |
| S-1/A | Amended registration statement | Jan 18, 2024 | — |
| CORRESP | Letter to the SEC | Jan 17, 2024 | — |
| CORRESP | Letter to the SEC | Jan 17, 2024 | — |
| S-1/A | Amended registration statement | Jan 17, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| 8-K |
Current report
Results of operations, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jan 16, 2024 | Jan 10, 2024 |
| S-1 | Registration statement | Jan 11, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jan 8, 2024 | Jan 8, 2024 |
| DEFA14A | Additional proxy material | Jan 4, 2024 | — |
| DEF 14A | Proxy statement | Dec 18, 2023 | Jan 8, 2024 |
| PRE 14A | Preliminary proxy statement | Dec 8, 2023 | Dec 7, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 8, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 4, 2023 | Nov 30, 2023 |
| 424B5 | Prospectus supplement | Dec 1, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 9, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Listing notice
|
Oct 27, 2023 | Oct 26, 2023 |
| 424B5 | Prospectus supplement | Oct 26, 2023 | — |
| 8-K |
Current report
Other events
|
Oct 24, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 28, 2023 | Sep 25, 2023 |
| 424B4 | Prospectus | Sep 27, 2023 | — |
| EFFECT | Filing | Sep 25, 2023 | — |
| CORRESP | Letter to the SEC | Sep 25, 2023 | — |
| CORRESP | Letter to the SEC | Sep 25, 2023 | — |
| CORRESP | Letter to the SEC | Sep 25, 2023 | — |
| CORRESP | Letter to the SEC | Sep 25, 2023 | — |
| S-1/A | Amended registration statement | Sep 25, 2023 | — |
| CORRESP | Letter to the SEC | Sep 22, 2023 | — |
| CORRESP | Letter to the SEC | Sep 22, 2023 | — |
| CORRESP | Letter to the SEC | Sep 22, 2023 | — |
| CORRESP | Letter to the SEC | Sep 15, 2023 | — |
| CORRESP | Letter to the SEC | Sep 15, 2023 | — |
| S-1/A | Amended registration statement | Sep 11, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2023 | — |
| S-1 | Registration statement | Aug 29, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 24, 2023 | Aug 23, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Listing notice
|
Aug 4, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 28, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Material agreement, Listing notice, Other events
|
Jun 8, 2023 | Jun 6, 2023 |
| 424B4 | Prospectus | Jun 7, 2023 | — |
| EFFECT | Filing | Jun 6, 2023 | — |
| CORRESP | Letter to the SEC | Jun 6, 2023 | — |
| S-1/A | Amended registration statement | Jun 6, 2023 | — |
| CORRESP | Letter to the SEC | Jun 5, 2023 | — |
| S-1/A | Amended registration statement | Jun 5, 2023 | — |
| UPLOAD | Letter from the SEC | May 25, 2023 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
May 22, 2023 | May 19, 2023 |
| 8-K |
Current report
Officer or director change
|
May 19, 2023 | May 18, 2023 |
| S-1 | Registration statement | May 19, 2023 | — |
| 8-K |
Current report
Listing notice
|
May 18, 2023 | May 16, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 14, 2023 | Apr 13, 2023 |
| 424B5 | Prospectus supplement | Apr 14, 2023 | — |
| ARS | Annual report to shareholders | Apr 10, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 10, 2023 | May 10, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2023 | May 10, 2023 |
| 8-K | Current report | Mar 31, 2023 | Mar 29, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Unregistered share sale, Other events
|
Feb 17, 2023 | Feb 16, 2023 |
| 424B5 | Prospectus supplement | Feb 17, 2023 | — |
| RW | Filing | Feb 14, 2023 | — |
| S-1 | Registration statement | Feb 1, 2023 | — |
| 8-K |
Current report
Results of operations
|
Feb 1, 2023 | Feb 1, 2023 |
| EFFECT | Filing | Dec 16, 2022 | — |
| CORRESP | Letter to the SEC | Dec 14, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 14, 2022 | — |
| S-3 | Shelf registration | Dec 13, 2022 | — |
| 8-K |
Current report
Listing notice
|
Dec 9, 2022 | Dec 9, 2022 |
| RW | Corresp | Dec 6, 2022 | — |
| S-1/A | Amended registration statement | Nov 30, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 30, 2022 | Nov 30, 2022 |
| S-1 | Registration statement | Nov 28, 2022 | — |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RNAZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829635
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.